pefcalcitol
Small moleculeexperimental
Clinical trial activity
10 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
7
Phase 3
4
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00884169)
Timeline
Indications
Mechanism of action
- Vitamin D receptorAGONIST
VDR agonist
vitamin D3 analogue
Chemistry & pharmacology
Loading structure…
SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O- Mol. weight
- 519.55 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3989862 ↗
- ChEMBLCHEMBL3137307 ↗
Also known as
- m5181
- m5181
- m518101
- m518101
- pefcalcitol
- pefcalcitol
- pefcalcitol
- pefcalcitol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02970331 | Phase 2 | Nov 1, 2016 | Cutanea Life Sciences, Inc. |
| NCT02256930 | Phase 1 | Sep 1, 2014 | Maruho Co., Ltd. |
| NCT02227069 | Phase 1 | Sep 1, 2014 | Maruho Co., Ltd. |
| NCT01989429 | Phase 3 | Oct 1, 2013 | Maruho Co., Ltd., University of Lubeck |
| NCT01908595 | Phase 3 | Aug 1, 2013 | Maruho Co., Ltd. |
| NCT01878461 | Phase 3 | Jun 1, 2013 | Maruho Co., Ltd. |
| NCT01873677 | Phase 3 | Jun 1, 2013 | Maruho Co., Ltd. |
| NCT01844973 | Phase 1 | Apr 1, 2013 | Maruho Co., Ltd. |
| NCT01301157 | Phase 2 | Feb 1, 2011 | Maruho Co., Ltd. |
| NCT00884169 | Phase 2 | Jul 1, 2009 | Maruho Co., Ltd. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Maruho Co., Ltd. | For profit | 9 | 9 | 3 | 2009 |
| Cutanea Life Sciences, Inc. | For profit | 1 | 1 | 1 | 2016 |
| University of Lubeck | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1